A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma.
Michael D. Prados, S. Clifford Schold SC JR, Howard A. Fine, Kurt Jaeckle, Fred Hochberg, Laszlo Mechtler, Michael R. Fetell, Surasak Phuphanich, Lynn Feun, Todd J. Janus, Kathleen Ford, and William Graney
Neuro Oncol. 2003 April; 5(2): 96–103. PMCID: PMC1920676